Latest News about SRNE
Recent news which mentions SRNE
Sorrento Therapeutics Stock Looks To Form Bullish Falling Wedge
Today 16:42 EDT
Tickers
SRNE
From Benzinga
From Motley Fool
7 Pharmaceutical Stocks That Could Get a Covid Hangover
April 01, 2021
From InvestorPlace
From Benzinga
From Benzinga
Take Your Profits! 7 Covid Winners to Sell Now
March 23, 2021
From InvestorPlace
From InvestorPlace
The Dip Is an Opportunity in Sorrento Therapeutics Stock
March 10, 2021
Tickers
SRNE
From InvestorPlace
Tickers
SRNE
From InvestorPlace
Pilots Ask FedEx To Halt Hong Kong Layovers Over COVID Rules
March 08, 2021
From Benzinga
40 Stocks Moving in Monday's Pre-Market Session
March 08, 2021
From Benzinga
From Motley Fool
Why Ovid, KemPharm, Sorrento, Aquestive Are Rallying
March 03, 2021
From Benzinga
The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study
March 03, 2021
From Benzinga
16 Stocks Moving In Tuesday's After-Hours Session
March 02, 2021
From Benzinga
From Benzinga
Ocugen Stock Isn’t Pricing In the Hard Road Ahead
March 01, 2021
From InvestorPlace
36 Stocks Moving in Monday's Pre-Market Session
February 22, 2021
From Benzinga
Is Sorrento Therapeutics a Good Coronavirus Stock to Buy?
February 21, 2021
Tickers
SRNE
From Motley Fool
From Benzinga
10 Health Care Stocks With Unusual Options Alerts In Today's Session
February 12, 2021
From Benzinga
Tickers
SRNE
From Motley Fool
From OTC
How Risky Are These Heavily Shorted COVID Stocks?
February 11, 2021
From Motley Fool
4 Penny Stocks on the Run: Aeterna Zentaris (NASDAQ: AEZS), Alpine 4 Technologies (OTC US: ALPP), Enzolytics (OTC US: ENZC), and Ocugen (NASDAQ: OCGN)
February 10, 2021
From OTC
10 Health Care Stocks With Unusual Options Alerts In Today's Session
February 08, 2021
From Benzinga
From OTC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.